Antimicrobial Resistance Centre

Inspiring innovation in AMR research through interdisciplinary and international engagements.

Book Launch and Panel Discussion | Superbugs: An Arms Race against Bacteria

Featuring

 

Details

Date: Thursday 26 April

Time: 17:30 – 19:00

Venue: John Snow Lecture Theatre, Keppel Street

Following the talk and panel discussion, a book sales and signing will take place in the South Courtyard Café.

Superbugs will be available to purchase at the event (cash and card) for the special price of £15.

Find out more.

About the Antimicrobial Resistance (AMR) Centre

AMR is a threat to life and healthcare globally. With increasing levels of international concern about AMR, we need high quality research and evidence to guide action. The London School of Hygiene & Tropical Medicine is unique in the breadth of disciplines used to meet this complex challenge. These range from microbiology and clinical medicine to social studies and economics. The School’s Antimicrobial Resistance Centre, launched in 2016, will foster connections between these scientific approaches, generating innovative approaches to science and policy.

The Centre is based on five disciplinary pillars:

The aims of the AMR Centre are:

  1. Promote and facilitate high quality research into AMR that builds on and exploits disciplinary strengths across LSHTM.
  2. Facilitate AMR related funding responses and collaboration opportunities.
  3. Provide an interface for LSHTM’s AMR research for staff, public, press and wider research communities.
  4. Provide educational materials on AMR.

Spotlight 23/04/18 | Successful treatment of “world’s worst” antibiotic resistant “super-gonorrhoea”

Late last week, Public Health England (PHE) reported that a UK man infected with the “world’s worst” antibiotic resistant “super-gonorrhoea” has been successfully treated. The case was initially announced by PHE in March, and widely publicized in the mainstream news media. The infection, contracted in southeast Asia, is resistant to both elements of the recommended dual first-line treatment, azithromycin and ceftriaxone. Based on susceptibility testing, the patient received a course of ertapenem (a broad-spectrum carbapenem antibiotic administered intravenously), which successfully cleared the infection. Two subsequent cases with similar resistance profiles have been reported in Australia.

Read more.

Metrics and Methods for Assessing Antibiotic Use – Roundtable

In late November 2017, the AMR Centre hosted 38 researchers, health and policy professionals in London for a roundtable to discuss how best antibiotic use can be measured in a way that informs strategies to address antibiotic resistance both nationally and internationally.

Read about the roundtable discussion here.

VIDEO | Rise and fall of the magic bullet

AMR Centre member Sam Willcocks walks us through the rise and fall of antibiotics, and shows us why we need to think carefully about how we harness new technology so that we can continue to do good.

Watch